Drug
Kk2269
Kk2269: highest development phase Phase 1, developed by Kyowa Kirin. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Kyowa Kirin
Trials
| Drug | Phase | Indication |
|---|---|---|
| KK2269 NCT06266299 | Phase 1 | Advanced Solid Tumor |
Latest
No recent events.
Follow Kk2269 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.